Many Patients Prescribed Drugs of Little Benefit Months Before Death

During their waning months of life, many elderly patients are often given many medications that may serve little or no benefit to them, yet carry the potential for serious adverse events and drug-drug interactions.

Researchers in Sweden examined the prescription drug history of nearly 500,000 elderly people in the 12 months before they died. They found that in that final year, almost half — 47% — were taking at least 10 prescription drugs, they reported in the American Journal of Medicine. Those taking cancer drugs had the largest increase of drugs taken over the course of their final year.

While many patients were given drugs such as pain relievers to relieve symptoms of medical conditions, they also continued to take medications that are considered long-term preventative treatments, such as beta blockers used for heart conditions, ACE inhibitors for high blood pressure and statins to reduce cholesterol. The researchers questioned whether patients close to death should continue to take drugs whose clinical benefits would not be achieved before they passed away.

“Physicians should consider discontinuing drugs that may be effective and otherwise appropriate, but whose potential harms outweigh the benefits that patients can reasonably expect before death occurs,” the researchers noted. They added that “the process of de-prescribing requires timely dialogue between the patient, family, and physician, and close monitoring of symptoms.”

The authors also called for the development of clinical guidelines to help physicians reduce potentially futile drug treatments near the end of life.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

Can Convalescent Plasma Treat COVID-19 Patients?

Can Convalescent Plasma Treat COVID-19 Patients?

One of the most promising treatments for COVID-19 is convalescent plasma, a component of blood. People who have been infected with the virus and are now healthy have developed COVID-19-fighting antibodies, which, the theory is, can be given to people currently sick with COVID-19 so that those antibodies can boost…

  • Advertisement